Similar articles

• New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines.

  Lederer E. Lederer E. Drugs Exp Clin Res. 1986;12(6-7):429-40. Drugs Exp Clin Res. 1986. PMID: 3527628 Review.
• Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.

  Bahr GM. Bahr GM. J Antimicrob Chemother. 2003 Jan;51(1):5-8. doi: 10.1093/jac/dkg063. J Antimicrob Chemother. 2003. PMID: 12493780 Review. No abstract available.
• Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.

  Heymer B, Finger H, Wirsing CH. Heymer B, et al. Z Immunitatsforsch Immunobiol. 1978 Oct;155(1):87-92. Z Immunitatsforsch Immunobiol. 1978. PMID: 706536
• [The principles in correcting secondary immunodeficiencies by using 2 immunomodulators of differing character--purified staphylococcal anatoxin and likopid].

  Semenova IB. Semenova IB. Zh Mikrobiol Epidemiol Immunobiol. 1998 Jan-Feb;(1):100-4. Zh Mikrobiol Epidemiol Immunobiol. 1998. PMID: 9532703 Review. Russian. No abstract available.
• [New technology of vaccine production--international prospect of the development. Development of synthetic immunologic adjuvants and MDP-antigen binding vaccines].

  Azuma I. Azuma I. Nihon Rinsho. 1987 Oct;45(10):2355-61. Nihon Rinsho. 1987. PMID: 3448269 Japanese. No abstract available.